Baker McKenzie

Healthcare & Life Sciences

Insight
13 January 2020
Global Transactions in the Healthcare & Life Sciences Sector: Fundamental Strengths to Drive Recovery from a Short-Term Slowdown
Though the healthcare and life sciences sector is not immune to the economic and geopolitical headwinds affecting all industries, its underlying strength will continue to promote dealmaking. 
Read More

Healthcare and life sciences are some of the largest and fastest-growing industries in the world, in addition to being the most regulated, with rapidly changing rules and regulations that often conflict from one country to another. Healthcare and life sciences companies face a number of challenges, including trying to understand how these laws impact their market and M&A strategies while contending with rising R&D costs, loss of patent protection of blockbuster drugs, pricing pressures, and competition from generics. Rapid convergence of the healthcare, life sciences and technology sectors requires even more legal expertise given the additional data privacy and intellectual property concerns.

Insight
27 March 2020
Manufacturing Personal Protective Equipment to Tackle Coronavirus
As COVID-19 infections increase globally, the concern about a shortage of personal protective equipment for healthcare workers also broadens.
Insight
26 March 2020
Governors of New York, New Jersey and Connecticut Issue Executive Orders Mandating Statewide Restrictions Due to COVID-19
Governors of Issue Executive Orders mandating statewide restrictions due to COVID-19. 
Insight
26 March 2020
Update: Summary of Texas Stay Home Orders
Order requires residents to remain inside except for "Essential Activities" and requires non-essential businesses close their facilities.
Insight
26 March 2020
Australia: Changes to the Hospitality Industry (General) Award 2010 in Response to COVID-19 Pandemic
The amendments apply from 24 March 2020 until 30 June 2020.
Insight
26 March 2020
Hand Sanitiser - Switching Production to Tackle Coronavirus
As COVID-19 infections increase globally, the concern about a shortage of life-saving equipment and other essential supplies to prevent the spread of the virus and care for the sick also broadens. To ...
Insight
25 March 2020
UK Medical Research: COVID-19's Impact
The UK’s Health Research Authority (HRA) and MHRA have published guidance on the impact of COVID-19 on medical research in the UK.
Insight
25 March 2020
US: Telehealth Services in the COVID-19 Pandemic: OCR Issues Instructive Guidelines Regarding HIPAA Enforcement
The US Office of Civil Rights has issued supplemental guidance on provision of telehealth services ...
Insight
23 March 2020
Coronavirus - Legal Guide for Germany
Due to the situation caused by the spread of COVID-19, we have published a "Coronavirus - Legal Guide for Germany".
Insight
23 March 2020
Government Plans for Safeguarding the UK's Future: Emergency Coronavirus Legislation
The UK Government's emergency powers to respond to the Coronavirus pandemic are, at least in part, expected to become effective before the end of March.
Insight
23 March 2020
COVID-19: Argentina Speeds Up Import Clearance for Sanitary Supplies
Action taken will simplify the import clearance process of certain critical sanitary supplies.
View All Insight
News
21 February 2020
Baker McKenzie advised Carnegie and Zonda in connection with Cantargia's ~ SEK 410 million directed share issue
Cantargia AB (publ) has completed a directed share issue of approximately SEK 410 million before ...
News
20 February 2020
Baker McKenzie Advises CytoSorbents in Agreement with China Medical System Holdings Limited to Bring CytoSorb® to Mainland China to Treat Critically Ill Patients with COVID-19 Coronavirus Infection
Baker McKenzie represented CytoSorbents Corporation in an agreement with China Medical System ...
News
10 February 2020
US Continues to Lead in Biopharma Activity, China’s Rapid Pace of Innovation Ramps Up and Europe Continues as Solid Breeding Ground for Biopharma
The US continues to lead in terms of biotech and pharma activity on the capital markets.
News
30 January 2020
Baker McKenzie advises shareholders of Biopharma on the sale of pharmaceutical business to Stada AG
Baker McKenzie advised the shareholders of Biopharma on the carve-out of its non-plasma business and its further sale to Stada AG.
News
11 December 2019
Cross-Border Activity Slows Overall, But Domestic IPO Markets Buck Downward Trend
Our Cross-Border IPO Index 2019 finds that geopolitical uncertainties, particularly in major financial markets, dampened IPO activity and left investors waiting on the sidelines.
News
02 December 2019
Baker McKenzie Advises Pfizer in Restructuring and Joint Venture with GlaxoSmithKline in Mexico
The combination results in a world-leading consumer healthcare business.
News
14 November 2019
Novaliq and Jiangsu Hengrui Medicine Announce Strategic Collaboration
Baker McKenzie advises Novaliq in all legal aspects of the license agreement.
News
13 November 2019
UK consumer trust is proving a barrier to the adoption of digital healthcare technologies
Less than half (47%) of consumers trust digital health products.
News
05 November 2019
American Hospital Dubai partners with Livio in IVF joint venture
Under the agreement, the joint venture will establish an IVF center with a specialized laboratory as per Livio standards.
News
21 October 2019
Baker McKenzie advises GSK on the divestment of two commercial vaccines to Bavarian Nordic
Baker McKenzie is advising GlaxoSmithKline plc (GSK) on the sale of its travel vaccines Rabipur / Rabavert and Encepur to Bavarian Nordic.
View All News
  • Ranked in the Top 10 Law Firms in the world for Life Sciences, Chambers Global
  • Ranked Band 1 for Life Sciences, Chambers Asia Pacific 2014-2018
  • Medical Law Firm of the Year, ALB Southeast Asia Awards 2017
  • Most Innovative Use of Technology for the Pharma MapApp, FT Most Innovative Lawyer Awards, 2015
  • No. 1 Healthcare M&A firm by deal volume for past three years, Thomson Reuters 2017
  • No. 1 Healthcare M&A firm by cross-border deal volume for past five years, Thomson Reuters 2017

 

How We Can Help

About Us

Learn about our Global Healthcare & Life Sciences Industry Group in 3 minutes

Healthcare MapApp

Access real-time information on the laws and regulations affecting the healthcare and life sciences industries in more than 50 countries

Global Healthcare and Life Sciences Webinar Series

Learn about a spectrum of legal issues and hot topics in the healthcare and life sciences industries

Clinical Trials Handbook

Outlines the legal framework governing clinical trials of medicinal products in 34 jurisdictions

Promoting Medical Products Globally

Understand legal developments and regulations related to ethical business interactions between medical companies and healthcare professionals in 35 countries

Key Contacts

We use cookies on our website. To learn more about how we use cookies and how to change your cookies settings if you do not want cookies on your computer, please see our Privacy and Cookies Statement. By continuing to use this site you consent to our use of cookies in accordance with our Privacy and Cookies Statement.
View Statement